BeStock  
Markets › Compare › SNDX vs PHAR

SNDX vs PHAR

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
SNDX · Syndax Pharmaceuticals$8.72 ▼ 4.49%
PHAR · Pharming Group$11.54 ▼ 5.18%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

386285109132Nov 24, '25May 26, '26Nov 20, '26
  • SNDX -55.9%
  • PHAR -32.6%

Head to head

MetricSNDXPHAR
Price$8.72$11.54
Change today▼ 4.49%▼ 5.18%
Market cap$785.05M$816.78M
Return, 3 months-55.4%+0.7%
Return, year to date-58.5%-34.7%
Return, 1 year-50.0%-29.0%
P/E (TTM)–35.0
P/B-45.72.8
P/E percentile vs own 5y66th77th
Dividend yield––
Revenue growth (YoY, latest qtr)+81.6%+20.8%
Net profit growth (YoY)+18.6%+197.1%
Gross margin92.2%85.1%
Operating margin-61.7%6.7%
Net margin-72.3%6.3%
Return on equity-426.4%8.7%
Analyst target vs. price+332.0%+238.0%
Analyst buy share83%100%
RSI (14)2845
30-day volatility117.2%59.3%
Max drawdown, 1 year-66.0%-57.0%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • PHAR is the largest of the group by market value.
  • PHAR has returned the most over the past year.
  • SNDX is growing revenue fastest.
  • PHAR keeps the most profit per dollar of sales.
  • PHAR has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top